These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 15741790)

  • 1. Race/ethnicity and insurance status as factors associated with ADHD treatment patterns.
    Stevens J; Harman JS; Kelleher KJ
    J Child Adolesc Psychopharmacol; 2005 Feb; 15(1):88-96. PubMed ID: 15741790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Racial and ethnic differences in ADHD and LD in young school-age children: parental reports in the National Health Interview Survey.
    Pastor PN; Reuben CA
    Public Health Rep; 2005; 120(4):383-92. PubMed ID: 16025718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Racial and ethnic disparities in parent-reported diagnosis of ADHD: National Survey of Children's Health (2003, 2007, and 2011).
    Collins KP; Cleary SD
    J Clin Psychiatry; 2016 Jan; 77(1):52-9. PubMed ID: 26761486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medication patterns for attention-deficit/hyperactivity disorder and comorbid psychiatric conditions in a low-income population.
    Radigan M; Lannon P; Roohan P; Gesten F
    J Child Adolesc Psychopharmacol; 2005 Feb; 15(1):44-56. PubMed ID: 15741785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychotherapeutic medication patterns for youths with attention-deficit/hyperactivity disorder.
    Zito JM; Safer DJ; dosReis S; Magder LS; Gardner JF; Zarin DA
    Arch Pediatr Adolesc Med; 1999 Dec; 153(12):1257-63. PubMed ID: 10591302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. National trends in the treatment of attention deficit hyperactivity disorder.
    Olfson M; Gameroff MJ; Marcus SC; Jensen PS
    Am J Psychiatry; 2003 Jun; 160(6):1071-7. PubMed ID: 12777264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacotherapy with atomoxetine for US children and adolescents.
    Bhatara VS; Aparasu RR
    Ann Clin Psychiatry; 2007; 19(3):175-80. PubMed ID: 17729019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utilization of pharmacologic treatment in youths with attention deficit/hyperactivity disorder in Medicaid database.
    Winterstein AG; Gerhard T; Shuster J; Zito J; Johnson M; Liu H; Saidi A
    Ann Pharmacother; 2008 Jan; 42(1):24-31. PubMed ID: 18042808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outpatient Visits and Medication Prescribing for US Children With Mental Health Conditions.
    Anderson LE; Chen ML; Perrin JM; Van Cleave J
    Pediatrics; 2015 Nov; 136(5):e1178-85. PubMed ID: 26459647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Racial and Ethnic Disparities in ADHD Diagnosis and Treatment.
    Coker TR; Elliott MN; Toomey SL; Schwebel DC; Cuccaro P; Tortolero Emery S; Davies SL; Visser SN; Schuster MA
    Pediatrics; 2016 Sep; 138(3):. PubMed ID: 27553219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ethnic and regional differences in primary care visits for attention-deficit hyperactivity disorder.
    Stevens J; Harman JS; Kelleher KJ
    J Dev Behav Pediatr; 2004 Oct; 25(5):318-25. PubMed ID: 15502548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Association Between Race/Ethnicity and Socioeconomic Factors and the Diagnosis and Treatment of Children with Attention-Deficit Hyperactivity Disorder.
    Bax AC; Bard DE; Cuffe SP; McKeown RE; Wolraich ML
    J Dev Behav Pediatr; 2019; 40(2):81-91. PubMed ID: 30407938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attention Deficit Hyperactivity Disorder Medication Use Among Teens and Young Adults.
    Johansen ME; Matic K; McAlearney AS
    J Adolesc Health; 2015 Aug; 57(2):192-7. PubMed ID: 26026476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. National estimates and factors associated with medication treatment for childhood attention-deficit/hyperactivity disorder.
    Visser SN; Lesesne CA; Perou R
    Pediatrics; 2007 Feb; 119 Suppl 1():S99-106. PubMed ID: 17272592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emergency department visits among pediatric patients for sports-related injury: basic epidemiology and impact of race/ethnicity and insurance status.
    Simon TD; Bublitz C; Hambidge SJ
    Pediatr Emerg Care; 2006 May; 22(5):309-15. PubMed ID: 16714957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis of attention-deficit/hyperactivity disorder and use of psychotropic medication in very young children.
    Rappley MD; Mullan PB; Alvarez FJ; Eneli IU; Wang J; Gardiner JC
    Arch Pediatr Adolesc Med; 1999 Oct; 153(10):1039-45. PubMed ID: 10520611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and correlates of psychotropic medication use in adolescents with an autism spectrum disorder with and without caregiver-reported attention-deficit/hyperactivity disorder.
    Frazier TW; Shattuck PT; Narendorf SC; Cooper BP; Wagner M; Spitznagel EL
    J Child Adolesc Psychopharmacol; 2011 Dec; 21(6):571-9. PubMed ID: 22166171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Twenty-Year Trends in Diagnosed Attention-Deficit/Hyperactivity Disorder Among US Children and Adolescents, 1997-2016.
    Xu G; Strathearn L; Liu B; Yang B; Bao W
    JAMA Netw Open; 2018 Aug; 1(4):e181471. PubMed ID: 30646132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mental health in the United States. Prevalence of diagnosis and medication treatment for attention-deficit/hyperactivity disorder--United States, 2003.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2005 Sep; 54(34):842-7. PubMed ID: 16138075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Explaining racial and ethnic differences in children's use of stimulant medications.
    Hudson JL; Miller GE; Kirby JB
    Med Care; 2007 Nov; 45(11):1068-75. PubMed ID: 18049347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.